Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-21

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved the original application for a generic ketorolac tromethamine product (Toradol) manufactured by Zydus Pharmaceuticals (USA) Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toradol (ketorolac tromethamine) (ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)